Question 1

What specific benefits might I expect from fulvestrant compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer clinical trial (NCT00272740). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer clinical trial (NCT00272740). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with fulvestrant?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer clinical trial (NCT00272740). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic for treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer clinical trial (NCT00272740). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer clinical trial (NCT00272740). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any other treatment options I should consider alongside this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer clinical trial (NCT00272740). Contact the study team or your healthcare provider for specific answers.

What this study is about